Celentyx’s services and partnering opportunities utilise the proprietary Immuno-Profiling™ platform to provide rapid analysis of drug action on physiological and pathological human immune tissues and cells.
To discuss our partnering opportunities please contact our Commercial Manager Dr Catherine Brady